Literature DB >> 21380583

Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy.

Kazuki Takeishi1, Ken Shirabe, Jun Muto, Takeo Toshima, Akinobu Taketomi, Yoshihiko Maehara.   

Abstract

BACKGROUND: There are few reports about hepatectomy for young patients with hepatocellular carcinoma (HCC), and the significance of resection for young patients remains unknown. The present study aimed to investigate retrospectively the clinicopathological features and outcomes after hepatectomy of young HCC patients.
METHODS: Among 610 patients who underwent curative hepatectomy for HCC between January 1987 and December 2007, 13 patients younger than 40 years of age were defined as the young group. Because none of the young group had hepatitis C virus antibodies (HCVAb), 246 patients aged above 40 years without HCVAb were defined as the older group. The clinicopathological findings and outcomes after hepatectomy were compared between the two groups.
RESULTS: In the young group, 7 patients had hepatitis B surface antigen and 3 other patients had hepatitis B core antibodies. The young group had better liver function but more advanced HCC, with a large tumor size and a high incidence of portal vein invasion compared with the older group. Major hepatectomy was more frequently chosen in the young group than in the older group. There was no significant difference in the incidences of postoperative complications. The overall survival tended to be better in the young group than in the older group (p=0.057).
CONCLUSIONS: Hepatitis B virus-related HCC was common in the younger group of patients reported here. Although the young patients had advanced HCC, there were no significant differences in the complication rate and the overall survival rate of the young and older groups. Aggressive hepatic resection for young patients would contribute to improved survival and should be recommended.

Entities:  

Mesh:

Year:  2011        PMID: 21380583     DOI: 10.1007/s00268-011-1017-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  40 in total

1.  Surgical indications for advanced hepatocellular carcinoma.

Authors:  M Shimada; Y Yamashita; T Hamatsu; T Rikimaru; H Hasegawa; T Gion; K Shirabe; K Takenaka; K Sugimachi
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

Review 2.  Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes.

Authors:  P Bannasch
Journal:  Prog Liver Dis       Date:  1996

3.  Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.

Authors:  Chien-Hung Chen; Ting-Tsung Chang; Ken-Sheng Cheng; Wei-Wen Su; Sheng-Shun Yang; Hans Hsienhong Lin; Shun-Sheng Wu; Chuan-Mo Lee; Chi-Sin Changchien; Chien-Jen Chen; Jin-Chuan Sheu; Ding-Shinn Chen; Sheng-Nan Lu
Journal:  Liver Int       Date:  2006-09       Impact factor: 5.828

Review 4.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

Review 5.  Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and cystic dysplasia of the kidney.

Authors:  G Guariso; S Fiorio; G Altavilla; P G Gamba; T Toffolutti; M Chiesura-Corona; U Tedeschi; L Zancan
Journal:  Eur J Pediatr       Date:  1998-04       Impact factor: 3.183

6.  Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa.

Authors:  M C Kew
Journal:  Hepatology       Date:  1981 Jul-Aug       Impact factor: 17.425

7.  Hepatocellular carcinoma in Central Europe: prognostic features and survival.

Authors:  M Schöniger-Hekele; C Müller; M Kutilek; C Oesterreicher; P Ferenci; A Gangl
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 8.  Congenital absence of the portal vein.

Authors:  Y Matsuoka; K Ohtomo; T Okubo; J Nishikawa; T Mine; S Ohno
Journal:  Gastrointest Radiol       Date:  1992

9.  Gastric carcinoma in the young.

Authors:  P L Tso; W L Bringaze; A H Dauterive; P Correa; I Cohn
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

10.  Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study.

Authors:  C De Bac; T Stroffolini; G B Gaeta; G Taliani; G Giusti
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

View more
  12 in total

1.  Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.

Authors:  Noboru Harada; Ken Shirabe; Takashi Maeda; Hiroto Kayashima; Shintaro Takaki; Yoshihiko Maehara
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

2.  A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients.

Authors:  Cho Rok Lee; Jin Hong Lim; Sung Hoon Kim; Sang Hoon Ahn; Young Nyun Park; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-19       Impact factor: 3.452

3.  Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Authors:  Kazuki Takeishi; Hirofumi Kawanaka; Shinji Itoh; Norifumi Harimoto; Toru Ikegami; Tomoharu Yoshizumi; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 4.  Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.

Authors:  Yuesi Zhong; Meihai Deng; Ruiyun Xu
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

5.  Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients.

Authors:  Noboru Harada; Ken Shirabe; Takashi Maeda; Hiroto Kayashima; Teruyoshi Ishida; Yoshihiko Maehara
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

6.  Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices.

Authors:  Noboru Harada; Ken Shirabe; Takashi Maeda; Hiroto Kayashima; Teruyoshi Ishida; Yoshihiko Maehara
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

7.  Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database.

Authors:  Wenjie Zhang; Beicheng Sun
Journal:  Oncotarget       Date:  2015-01-20

8.  The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients.

Authors:  Ji Soo Lee; Jong Man Kim; Seunghwan Lee; Jin-Yong Choi; Wontae Cho; Gyu-Seoung Choi; Jae Berm Park; Choon Hyuck David Kwon; Sung Joo Kim; Jae-Won Joh
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2015-11-30

9.  The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients.

Authors:  Sang Yun Ha; Insuk Sohn; Soo Hyun Hwang; Jung Wook Yang; Cheol-Keun Park
Journal:  Oncotarget       Date:  2015-07-30

10.  Clinicopathological characteristics and prognostic factors in young patients after hepatectomy for hepatocellular carcinoma.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Kenji Wakayama; Yosuke Tsuruga; Tatsuhiko Kakisaka; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2013-03-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.